Medicare Enrolled

Dr. David Duncan, MD

Neurology · Neptune, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1945 ROUTE 33, Neptune, NJ 07753
7328973620
In practice since 2006 (20 years)
NPI: 1053364430 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Duncan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Duncan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Duncan

Dr. David Duncan is a neurology specialist in Neptune, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Duncan performed 156 Medicare services across 108 unique beneficiaries.

Between the years covered by Open Payments, Dr. Duncan received a total of $141,960 from 50 pharmaceutical and/or device companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Duncan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 156 Medicare services $141,960 industry payments

Medicare Practice Summary

Medicare Utilization ↗
156
Medicare services
Bottom 13% in NJ for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
108
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
113 $128 $608
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $96 $434
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$141,960
Total received (2018-2024)
Avg $20,280/year across 7 years
Top 3% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
875
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91,249 (64.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$41,207 (29.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,503 (6.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,206
2023
$16,198
2022
$20,015
2021
$20,709
2020
$24,084
2019
$38,864
2018
$15,883

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$3,613
Biogen, Inc.
$750
TG Therapeutics, Inc.
$684
Genentech USA, Inc.
$206
Alexion Pharmaceuticals, Inc.
$204
Novartis Pharmaceuticals Corporation
$186
Amgen Inc.
$170
ANI Pharmaceuticals, Inc.
$100
GENZYME CORPORATION
$69
Bioventus LLC
$49
Celgene Corporation
$48
Genentech, Inc.
$28
Lundbeck LLC
$18
ABBVIE INC.
$17
Acorda Therapeutics, Inc
$17
UCB, Inc.
$16
Vanda Pharmaceuticals Inc.
$16
BANNER LIFE SCIENCES, LLC
$16
Top 3 companies account for 81.3% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$27,412
Celgene Corporation
$25,306
Genentech USA, Inc.
$25,135
Biogen, Inc.
$17,986
EMD Serono, Inc.
$16,393
E.R. Squibb & Sons, L.L.C.
$15,860
Novartis Pharmaceuticals Corporation
$5,270
Alexion Pharmaceuticals, Inc.
$1,995
Janssen Global Services, LLC
$1,700
TG Therapeutics, Inc.
$684
Janssen Pharmaceuticals, Inc
$564
TG THERAPEUTICS, INC.
$363
Allergan Inc.
$351
Horizon Therapeutics plc
$337
Teva Pharmaceuticals USA, Inc.
$248
Philips Electronics North America Corporation
$228
Genentech, Inc.
$207
Viz.ai, Inc.
$170
Amgen Inc.
$170
Acorda Therapeutics, Inc
$139
Mallinckrodt LLC
$135
SANOFI-AVENTIS U.S. LLC
$116
Avanir Pharmaceuticals, Inc.
$115
Mallinckrodt Enterprises LLC
$114
ANI Pharmaceuticals, Inc.
$100
Novocure Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$88
Lundbeck LLC
$77
Medtronic USA, Inc.
$70
Allergan, Inc.
$56
Bioventus LLC
$49
Mallinckrodt Hospital Products Inc.
$48
Lilly USA, LLC
$40
ARBOR PHARMACEUTICALS, INC.
$37
Otsuka America Pharmaceutical, Inc.
$34
ABBVIE INC.
$32
Merck Sharp & Dohme Corporation
$26
Medtronic, Inc.
$25
ACADIA Pharmaceuticals Inc
$24
PFIZER INC.
$17
UCB, Inc.
$16
Vanda Pharmaceuticals Inc.
$16
AbbVie Inc.
$16
BANNER LIFE SCIENCES, LLC
$16
Axsome Therapeutics, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$14
Harmony Biosciences LLC
$13
Eisai Inc.
$13
NOVARTIS PHARMACEUTICALS CORPORATION
$11
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADAPTIVESTIM · AIMOVIG · AJOVY · AMPYRA · AUBAGIO · AVONEX · Austedo XR · BAFIERTAM · BELSOMRA · BONESCALPEL & SONICONE (O.R.) · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · COMIRNATY · COPAXONE · Dayvigo · EMGALITY · Enspryng · Evobrutinib · Fintepla · GILENYA · Glatiramer Acetate · Horizant · INBRIJA · INTELLIS ADAPTIVESTIM · KESIMPTA · LEMTRADA · MAYZENT · MS DISEASE STATE · Mavenclad · NUEDEXTA · NUPLAZID · Nuedexta · OCREVUS · Ocrevus · Optune · Ozanimod · PIPELINE-MS · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · Rebif · Respiratoriy Care Undiv · Rituxan · SOLIRIS · SPINRAZA · SUNOSI · SYNCHROMED · Soliris · Sunosi · TECFIDERA · TYSABRI · Trilogy 100 · Tysabri · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · Viz.AI LVO · Wakix · Wellcentive Undiv · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in NJ.

Looking for a neurology specialist in Neptune?
Compare neurologists in the Neptune area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
56
Per 100K population
8.7
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Duncan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Duncan experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Duncan performed 113 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Duncan receive payments from pharmaceutical companies?
Yes. Dr. Duncan received a total of $141,960 from 50 companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Duncan's costs compare to other neurologists in Neptune?
Dr. Duncan's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Duncan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →